Current Insights on Lipid-Based Nanosystems
Lipid-based nanosystems, including solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), cationic lipid nanoparticles, nanoemulsions, and liposomes, have been extensively studied to improve drug delivery through different administration routes. The main advantages of these syste...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (368 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993576086104498 |
---|---|
ctrlnum |
(CKB)5470000001633402 (oapen)https://directory.doabooks.org/handle/20.500.12854/95900 (EXLCZ)995470000001633402 |
collection |
bib_alma |
record_format |
marc |
spelling |
Silva, Ana Catarina edt Current Insights on Lipid-Based Nanosystems Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (368 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Lipid-based nanosystems, including solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), cationic lipid nanoparticles, nanoemulsions, and liposomes, have been extensively studied to improve drug delivery through different administration routes. The main advantages of these systems are their ability to protect, transport, and control the release of lipophilic and hydrophilic molecules (either small-molecular-weight molecules or macromolecules); the use of generally recognized as safe (GRAS) excipients that minimize the toxicity of the formulations; and the possibility to modulate pharmacokinetics and enable the site-specific delivery of encapsulated payloads. In addition, the versatility of lipid-based nanosystems has further been demonstrated for the delivery of vaccines, the protection of active cosmetic ingredients, and the improvement of moisturizing properties of cosmetic formulations.Lipid-based nanosystems are well established and there are already different commercially approved formulations for various human disorders. This success has paved the way for the diversification of the pipeline of development, to address unmet medical needs for several indications, such as cancer, neurological disorders, and autoimmune, genetic, and infectious diseases.This Special Issue aims to update readers on the latest research on lipid-based nanosystems, both at the preclinical and clinical levels. A series of 15 articles (six reviews and nine studies) is presented, with authors from 12 different countries, showing the globality of the investigations that are being carried out in this area. English Technology: general issues bicssc Echinococcus granulosus scolicidal nanoliposome juglone apoptotic activity hydrogel SLNs nose-to-brain delivery mucoadhesion quality by design antioxidant activity nasal administration nanostructured lipid carriers solid lipid nanoparticles in vitro cell cultures 3D nasal casts lung cancer targeted drug delivery lipid-based nanocarriers pulmonary delivery dry powder inhalers aerosols liposomes nanoemulsions nanotechnology biologically active compounds dermal drug delivery polyphenols phytophenols skin permeation chemotherapy radiotherapy active targeting passive targeting tumor immunoconjugate traditional liposome stealth liposome triggered release limitations of liposomes drug transfer in vitro release colloidal drug carriers lipid nanoparticles hydrogel beads cholesteryl nonanoate bovine serum albumin skin diseases lipid-based nanosystems cream ointment gel pH-sensitive liposome imidazole anticancer drug delivery multicellular spheroids dapagliflozin Box-Behnken design FTIR DSC XRD SEM AFM in vitro Franz diffusion cells lipid-based nanoparticles nanocarrier surface charge delivery systems chronic treatment mice anti-oxidant activity hepatoprotective effect phospholipid phytosomes Silymarin Colorectal Cancer Niosomes Oxaliplatin Paclitaxel d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) therapeutic nucleic acids schizophrenia quetiapine fumarate glycerosomes central composite rotatable design bioavailability pharmacokinetic 3-0365-6166-8 Moreira, João edt Sousa Lobo, José Manuel edt Silva, Ana Catarina oth Moreira, João oth Sousa Lobo, José Manuel oth |
language |
English |
format |
eBook |
author2 |
Moreira, João Sousa Lobo, José Manuel Silva, Ana Catarina Moreira, João Sousa Lobo, José Manuel |
author_facet |
Moreira, João Sousa Lobo, José Manuel Silva, Ana Catarina Moreira, João Sousa Lobo, José Manuel |
author2_variant |
a c s ac acs j m jm l j m s ljm ljms |
author2_role |
HerausgeberIn HerausgeberIn Sonstige Sonstige Sonstige |
title |
Current Insights on Lipid-Based Nanosystems |
spellingShingle |
Current Insights on Lipid-Based Nanosystems |
title_full |
Current Insights on Lipid-Based Nanosystems |
title_fullStr |
Current Insights on Lipid-Based Nanosystems |
title_full_unstemmed |
Current Insights on Lipid-Based Nanosystems |
title_auth |
Current Insights on Lipid-Based Nanosystems |
title_new |
Current Insights on Lipid-Based Nanosystems |
title_sort |
current insights on lipid-based nanosystems |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2022 |
physical |
1 electronic resource (368 p.) |
isbn |
3-0365-6165-X 3-0365-6166-8 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT silvaanacatarina currentinsightsonlipidbasednanosystems AT moreirajoao currentinsightsonlipidbasednanosystems AT sousalobojosemanuel currentinsightsonlipidbasednanosystems |
status_str |
n |
ids_txt_mv |
(CKB)5470000001633402 (oapen)https://directory.doabooks.org/handle/20.500.12854/95900 (EXLCZ)995470000001633402 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Current Insights on Lipid-Based Nanosystems |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField |
_version_ |
1796652733016571904 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05614nam-a2201405z--4500</leader><controlfield tag="001">993576086104498</controlfield><controlfield tag="005">20231214132827.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202301s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-0365-6165-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5470000001633402</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/95900</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995470000001633402</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Silva, Ana Catarina</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current Insights on Lipid-Based Nanosystems</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (368 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Lipid-based nanosystems, including solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), cationic lipid nanoparticles, nanoemulsions, and liposomes, have been extensively studied to improve drug delivery through different administration routes. The main advantages of these systems are their ability to protect, transport, and control the release of lipophilic and hydrophilic molecules (either small-molecular-weight molecules or macromolecules); the use of generally recognized as safe (GRAS) excipients that minimize the toxicity of the formulations; and the possibility to modulate pharmacokinetics and enable the site-specific delivery of encapsulated payloads. In addition, the versatility of lipid-based nanosystems has further been demonstrated for the delivery of vaccines, the protection of active cosmetic ingredients, and the improvement of moisturizing properties of cosmetic formulations.Lipid-based nanosystems are well established and there are already different commercially approved formulations for various human disorders. This success has paved the way for the diversification of the pipeline of development, to address unmet medical needs for several indications, such as cancer, neurological disorders, and autoimmune, genetic, and infectious diseases.This Special Issue aims to update readers on the latest research on lipid-based nanosystems, both at the preclinical and clinical levels. A series of 15 articles (six reviews and nine studies) is presented, with authors from 12 different countries, showing the globality of the investigations that are being carried out in this area.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Technology: general issues</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Echinococcus granulosus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">scolicidal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoliposome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">juglone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">apoptotic activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SLNs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nose-to-brain delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucoadhesion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality by design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antioxidant activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nasal administration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanostructured lipid carriers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solid lipid nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro cell cultures</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">3D nasal casts</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipid-based nanocarriers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pulmonary delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dry powder inhalers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aerosols</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liposomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoemulsions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanotechnology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biologically active compounds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dermal drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyphenols</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phytophenols</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">skin permeation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">active targeting</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">passive targeting</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunoconjugate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">traditional liposome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stealth liposome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triggered release</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">limitations of liposomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug transfer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro release</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colloidal drug carriers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipid nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel beads</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cholesteryl nonanoate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bovine serum albumin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">skin diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipid-based nanosystems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cream</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ointment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pH-sensitive</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liposome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">imidazole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anticancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multicellular spheroids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dapagliflozin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Box-Behnken design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FTIR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DSC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">XRD</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SEM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AFM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro Franz diffusion cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipid-based nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanocarrier</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">surface charge</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">delivery systems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chronic treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mice</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-oxidant activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatoprotective effect</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phospholipid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phytosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Silymarin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Colorectal Cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Niosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oxaliplatin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Paclitaxel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapeutic nucleic acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">schizophrenia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quetiapine fumarate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycerosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">central composite rotatable design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioavailability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacokinetic</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-6166-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moreira, João</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sousa Lobo, José Manuel</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silva, Ana Catarina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moreira, João</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sousa Lobo, José Manuel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:32:28 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-01-18 06:03:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345740790004498&Force_direct=true</subfield><subfield code="Z">5345740790004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345740790004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5342444980004498&Force_direct=true</subfield><subfield code="Z">5342444980004498</subfield><subfield code="b">Available</subfield><subfield code="8">5342444980004498</subfield></datafield></record></collection> |